![Wen Chen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wen Chen
Direktor/Vorstandsmitglied bei
EDDING GENOR GROUP HOLDINGS LIMITED
Profil
Mr. Wen Chen is an Independent Non-Executive Director at InventisBio, Co., Ltd., an Independent Non-Executive Director at Edding Genor Group Holdings Ltd., a partner at Yonjin Venture LLC and a Partner-Healthcare Investment at Shanghai Yonghua Capital Management Co. Ltd. He is on the Board of Directors at Shanghai Kinetic Medical Co., Ltd., InventisBio, Co., Ltd., Edding Genor Group Holdings Ltd., Innovex Medical Co., Ltd., Immvira Bioscience, Inc., TARIS BioMedical LLC and ITabMed Co., Ltd. Mr. Chen was previously employed as a General Manager-Business Development & Deputy GM by Hangzhou Tigermed Consulting Co., Ltd., a Research Associate by Amgen, Inc., a Principal by Astellas Institute for Regenerative Medicine, a Research Associate by Harvard University, and a Principal by New World China Land Ltd. He received his undergraduate degree from Purdue University, a graduate degree from Washington University School of Medicine and an MBA from Durham University Business School.
Aktive Positionen von Wen Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| EDDING GENOR GROUP HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 20.06.2020 |
| INVENTISBIO CO., LIMITED | Direktor/Vorstandsmitglied | 01.12.2020 |
| SHANGHAI KINETIC MEDICAL CO., LTD | Direktor/Vorstandsmitglied | 06.06.2025 |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Direktor/Vorstandsmitglied | 01.01.2017 |
Innovex Medical Co., Ltd.
 Innovex Medical Co., Ltd. Medical SpecialtiesHealth Technology Develops minimal invasive surgery devices | Direktor/Vorstandsmitglied | 25.01.2019 |
Itabmed Co., Ltd.
 Itabmed Co., Ltd. BiotechnologyHealth Technology Operates clinical-stage biotech company that discovery and development of immunotherapy products to treat cancer | Direktor/Vorstandsmitglied | - |
Immvira Bioscience, Inc.
 Immvira Bioscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops, manufactures and markets novel oncolytic immunotherapies and engineered exosome therapies | Direktor/Vorstandsmitglied | 01.01.2019 |
Shanghai Yonghua Capital Management Co. Ltd.
 Shanghai Yonghua Capital Management Co. Ltd. Investment ManagersFinance Manages private equity and venture capital funds | Corporate Officer/Principal | - |
Yonjin Venture LLC
 Yonjin Venture LLC Investment ManagersFinance Yonjin Venture invests in companies located in the United States and Europe. The firm targets companies operating in the fields diagnostics, therapeutics and medical devices. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Wen Chen
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Wen Chen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
83
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New World China Land Ltd.
 New World China Land Ltd. Real Estate DevelopmentFinance Provides residential and commercial & industrial real estate development services | Finance |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine | Health Technology |
Shanghai Kinetic Medical Co., Ltd.
 Shanghai Kinetic Medical Co., Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Health Technology |
Shanghai Yonghua Capital Management Co. Ltd.
Shanghai Yonghua Capital Management Co. Ltd. Investment ManagersFinance Manages private equity and venture capital funds | Finance |
Hangzhou Tigermed Consulting Co., Ltd.
 Hangzhou Tigermed Consulting Co., Ltd. BiotechnologyHealth Technology Operates as a contract research organization that focuses on clinical trails and drug development | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Durham University Business School
 Durham University Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovex Medical Co., Ltd.
Innovex Medical Co., Ltd. Medical SpecialtiesHealth Technology Develops minimal invasive surgery devices | Health Technology |
InventisBio, Co., Ltd.
 InventisBio, Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for oncology, autoimmune & metabolic diseases | Health Technology |
Genor Biopharma Holdings Ltd.
 Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
Yonjin Venture LLC
Yonjin Venture LLC Investment ManagersFinance Yonjin Venture invests in companies located in the United States and Europe. The firm targets companies operating in the fields diagnostics, therapeutics and medical devices. It provides financing for early stage capital requirements. | Finance |
Itabmed Co., Ltd.
Itabmed Co., Ltd. BiotechnologyHealth Technology Operates clinical-stage biotech company that discovery and development of immunotherapy products to treat cancer | Health Technology |
Immvira Bioscience, Inc.
Immvira Bioscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops, manufactures and markets novel oncolytic immunotherapies and engineered exosome therapies | Health Technology |
